Mark Eisenberg /newsroom/taxonomy/term/2317/all en Experts: GLP-1 drugs beyond weight loss /newsroom/channels/news/experts-glp-1-drugs-beyond-weight-loss-366258 <p>Ozempic and Wegovy are widely used to support weight loss and manage diabetes. But could this class of drugs, known as GLP-1 receptor agonists, also help treat heart failure, liver disease and even addiction?</p> <p><a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00295-0/fulltext?rss=yes">A new study</a> by researchers at °Ä¿Í¾º²Ê and the Lady Davis Institute for Medical Research at the Jewish General Hospital takes a closer look at their growing list of potential uses beyond diabetes and obesity.</p> Wed, 06 Aug 2025 17:46:33 +0000 keila.depape@mcgill.ca 324425 at /newsroom Mark Eisenberg /newsroom/mark-eisenberg Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 22772 at /newsroom